internal software thermal shift software version 1.4 (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
internal software thermal shift software version 1.4
Internal Software Thermal Shift Software Version 1.4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thermal+shift+software+version+1%2E4/thermal+shift+software+version+1+4/pm40227881-149-7-12
Average 90 stars, based on 1 article reviews
Internal Software Thermal Shift Software Version 1.4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thermal+shift+software+version+1%2E4/thermal+shift+software+version+1+4/pm40227881-149-7-12
Average 90 stars, based on 1 article reviews
internal software thermal shift software version 1.4 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8 H )-one inhibitors towards the salt-inducible kinase (SIK) subfamily Article Snippet: Data points were analyzed with the internal software ( Article Title: Synthesis of pyrazole-based macrocycles leads to a highly selective inhibitor for MST3 Article Snippet: Data points were analyzed with the Article Title: Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum Article Snippet: Data points were analyzed with the internal software ( Article Title: Synthesis of Pyrazole-Based Macrocycles Leads to a Highly Selective Inhibitor for MST3. Article Snippet: Data points were analyzed with the Article Title: Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor Article Snippet: Data points were analyzed with internal software ( Article Title: Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer's Disease Drug Candidate. Article Snippet: Leucettinibs are substituted 2-aminoimidazolin-4-ones (inspired by the marine sponge natural product Leucettamine B) developed as pharmacological inhibitors of DYRK1A (dualspecificity, tyrosine phosphorylation-regulated kinase 1A), a therapeutic target for indications such as Down syndrome and Alzheimer’s disease.. Leucettinib-21 was selected as a drug candidate following extensive structure/activity studies and multiparametric evaluations.. We here report its physicochemical properties (X-ray powder diffraction, differential scanning calorimetry, stability, solubility, crystal structure) and drug-like profile. Article Title: Development of Selective Pyrido[2,3- d ]pyrimidin-7(8 H )-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors. Article Snippet: Data points were analyzed with the internal software ( Software:Article Title: Chemogenomics for NR1 nuclear hormone receptors Article Snippet: .. Data were analyzed with the |